DI MARO, Salvatore
 Distribuzione geografica
Continente #
EU - Europa 4.972
NA - Nord America 2.714
AS - Asia 1.952
SA - Sud America 342
Continente sconosciuto - Info sul continente non disponibili 200
AF - Africa 30
OC - Oceania 2
Totale 10.212
Nazione #
RU - Federazione Russa 3.195
US - Stati Uniti d'America 2.618
IT - Italia 660
SG - Singapore 634
CN - Cina 455
IE - Irlanda 401
BR - Brasile 293
HK - Hong Kong 292
VN - Vietnam 250
GB - Regno Unito 203
DE - Germania 138
UA - Ucraina 117
IN - India 108
KR - Corea 72
CA - Canada 58
TR - Turchia 46
FI - Finlandia 44
SE - Svezia 36
GR - Grecia 30
NL - Olanda 30
FR - Francia 29
ES - Italia 23
AR - Argentina 20
MX - Messico 20
JP - Giappone 18
PK - Pakistan 18
BD - Bangladesh 17
AT - Austria 15
BE - Belgio 13
DK - Danimarca 13
EC - Ecuador 10
IQ - Iraq 8
PL - Polonia 8
VE - Venezuela 8
ZA - Sudafrica 6
CR - Costa Rica 5
MA - Marocco 5
UZ - Uzbekistan 5
ID - Indonesia 4
JM - Giamaica 4
CL - Cile 3
CO - Colombia 3
DZ - Algeria 3
HN - Honduras 3
IR - Iran 3
KE - Kenya 3
LK - Sri Lanka 3
PE - Perù 3
PT - Portogallo 3
RO - Romania 3
TN - Tunisia 3
AL - Albania 2
AM - Armenia 2
AZ - Azerbaigian 2
CH - Svizzera 2
EG - Egitto 2
EU - Europa 2
IL - Israele 2
MY - Malesia 2
NI - Nicaragua 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
BW - Botswana 1
CG - Congo 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
KG - Kirghizistan 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LT - Lituania 1
LV - Lettonia 1
ML - Mali 1
MQ - Martinica 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
PY - Paraguay 1
SA - Arabia Saudita 1
SC - Seychelles 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TW - Taiwan 1
UY - Uruguay 1
Totale 10.014
Città #
Moscow 1.173
Dublin 400
San Jose 311
Singapore 311
Hong Kong 291
Santa Clara 281
Chandler 268
Jacksonville 194
Ashburn 164
Council Bluffs 145
The Dalles 126
Ho Chi Minh City 106
Beijing 81
Bengaluru 72
Seoul 72
Hefei 70
Ann Arbor 67
Naples 62
Aversa 56
Princeton 53
Chicago 49
London 49
Medford 46
Hanoi 45
Roxbury 42
Munich 39
Bremen 38
Napoli 37
Caserta 32
Elora 31
New York 30
Los Angeles 27
São Paulo 27
Dallas 26
Istanbul 26
Rome 26
Milan 25
Des Moines 18
Barcelona 17
Boardman 16
Viterbo 15
Wilmington 15
Turku 14
Afragola 13
Brussels 12
Cesano Maderno 12
Phoenix 12
Tokyo 12
Woodbridge 12
Boydton 11
Copenhagen 11
San Mateo 11
Lahore 10
Mexico City 10
Mumbai 10
Amsterdam 9
Belo Horizonte 9
Biên Hòa 9
Cambridge 9
Da Nang 9
Piscataway 9
Brasília 8
Brooklyn 8
Florence 8
Haiphong 8
Montreal 8
Mountain View 8
Salvador 8
Vienna 8
Casal di Principe 7
Helsinki 7
Marcianise 7
Nanjing 7
Salerno 7
Thái Bình 7
Bologna 6
Falkenstein 6
Houston 6
Jinan 6
Memphis 6
Nuremberg 6
Orem 6
Rio de Janeiro 6
San Francisco 6
Volla 6
Atlanta 5
Bari 5
Lanzhou 5
Ninh Bình 5
Norwalk 5
Notre Dame 5
San Felice A Cancello 5
Seattle 5
Tashkent 5
Tianjin 5
Warsaw 5
Auburn Hills 4
Baghdad 4
Boltiere 4
Boston 4
Totale 5.420
Nome #
Antioxidant peptides from "Mozzarella di Bufala Campana DOP" after simulated gastrointestinal digestion: In vitro intestinal protection, bioavailability, and anti-haemolytic capacity 225
Cationic nucleopeptides as novel non-covalent carriers for the delivery of peptide nucleic acid (PNA) and RNA oligomers 210
Antitumor efficacy of Kisspeptin in human malignant mesothelioma cells 196
CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR Agonists 189
Inhibition of histone demethylases LSD1 and UTX regulates ERα signaling in breast cancer 187
Carprofen Analogues as Sirtuin Inhibitors: Enzyme and Cellular Studies 183
Boosting Fmoc Solid-Phase Peptide Synthesis by Ultrasonication 179
Irreversible inhibition of TRF2TRFH recruiting functions by a covalent cyclic peptide induces telomeric replication stress in cancer cells 178
Switchable Protecting Strategy for Solid Phase Synthesis of DNA and RNA Interacting Nucleopeptides 178
Tailoring the Structure of Cell Penetrating DNA and RNA Binding Nucleopeptides 175
Benzodeazaoxaflavins as sirtuin inhibitors with antiproliferative properties in cancer stem cells 173
Disulfide bond replacement with non-reducible side chain to tail macrolactamization for the development of potent and selective CXCR4 peptide antagonists endowed with flanking binding sites 165
Two novel SIRT1 activators, SCIC2 and SCIC2.1, enhance SIRT1-mediated effects in stress response and senescence 162
Structure-based lead optimization and biological evaluation of BAX direct activators as novel potential anticancer agents 159
Dual MET and SMO Negative Modulators Overcome Resistance to EGFR Inhibitors in Human Nonsmall Cell Lung Cancer 158
Benzofuroxane derivatives as multi-effective agents for the treatment of cardiovascular diabetic complications. Synthesis, functional evaluation, and molecular modeling studies 157
Disulfide Bond Replacement with 1,4- and 1,5-Disubstituted [1,2,3]-Triazole on C-X-C Chemokine Receptor Type 4 (CXCR4) Peptide Ligands: Small Changes that Make Big Differences 157
Comprehensive structural investigation of a potent and selective CXCR4 antagonist via crosslink modification 156
Ultrasound-assisted Peptide Nucleic Acids synthesis (US-PNAS) 155
Novel Peptide-Based PET Probe for Non-invasive Imaging of C-X-C Chemokine Receptor Type 4 (CXCR4) in Tumors 155
Exploring the N-Terminal Region of C-X-C Motif Chemokine 12 (CXCL12): Identification of Plasma-Stable Cyclic Peptides As Novel, Potent C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonists 151
Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors 150
A novel smaller β-defensin-derived peptide is active against multidrug-resistant bacterial strains 146
Discovery of N-Substituted-2-Oxoindolin Benzoylhydrazines as c-MET/SMO Modulators in EGFRi-Resistant Non-Small Cell Lung Cancer 145
tert-Butylcarbamate-Containing Histone Deacetylase Inhibitors: Apoptosis Induction, Cytodifferentiation, and Antiproliferative Activities in Cancer Cells 144
3-Aryl-[1,2,4]triazino[4,3-a ]benzimidazol-4(10 H)-one: A novel template for the design of highly selective A2B adenosine receptor antagonists 144
From genetic code to global health: the impact of nucleic acid vaccines on disease prevention and treatment 143
Lead Optimization of 2-Phenylindolylglyoxylyldipeptide Murine Double Minute (MDM)2/Translocator Protein (TSPO) Dual Inhibitors for the Treatment of Gliomas 143
Pharmacological folding chaperones act as allosteric ligands of Frizzled4 143
Stable Peptides Instead of Stapled Peptides: Highly Potent αvβ6-Selective Integrin Ligands 142
Structure-Activity Relationships and Biological Characterization of a Novel, Potent, and Serum Stable C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonist 142
Targeting CXCR4 reverts the suppressive activity of T-regulatory cells in renal cancer 142
Efficient Solid-Phase Synthesis of FK228 Analogues as Potent Antitumoral Agents 141
Simultaneous Targeting of RGD-Integrins and Dual Murine Double Minute Proteins in Glioblastoma Multiforme 140
Intestinal anti-inflammatory effect of a peptide derived from gastrointestinal digestion of buffalo (Bubalus bubalis) mozzarella cheese 140
Click-chemistry (CuAAC) trimerization of an αvβ6-integrin targeting Ga-68-peptide: Enhanced contrast for in-vivo PET imaging of human lung adenocarcinoma xenografts 140
Properly Substituted Analogues of BIX-01294 Lose Inhibition of G9a Histone Methyltransferase and Gain Selective Anti-DNA Methyltransferase 3A Activity 139
β-Cyclodextrin Inclusion Complexes with Model Pentapeptides: Role of the Tyrosine Position within the Peptide Chain. 138
The bright side of chemistry: Exploring synthetic peptide‐based anticancer vaccines 137
Halting the Spread of Herpes Simplex Virus-1: The Discovery of an Effective Dual αvβ6/αvβ8 Integrin Ligand 137
The organometallic ferrocene exhibits amplified anti-tumor activity by targeted delivery via highly selective ligands to αvβ3, αvβ6, or α5β1 integrins 137
Targeting CXCR4 impaired T regulatory function through PTEN in renal cancer patients 136
Functional Selectivity Revealed by N-Methylation Scanning of Human Urotensin II and Related Peptides 136
Streamlining Large Chemical Library Docking with Artificial Intelligence: the PyRMD2Dock Approach 135
From a Helix to a Small Cycle: Metadynamics-Inspired αvβ6 Integrin Selective Ligands 135
Lead Discovery of SARS-CoV-2 Main Protease Inhibitors through Covalent Docking-Based Virtual Screening 134
Water-soluble pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as human A 3 adenosine receptor antagonists 133
Selective Targeting of Integrin αvβ8 by a Highly Active Cyclic Peptide 131
Discovering Dually Active Anti-cancer Compounds with a Hybrid AI-structure-based Approach 130
Investigation of the Stereochemical-Dependent DNA and RNA Binding of Arginine-Based Nucleopeptides 128
Hepatocellular carcinoma (HCC) tumor microenvironment is more suppressive than colorectal cancer liver metastasis (CRLM) tumor microenvironment 127
Shading the TRF2 Recruiting Function: A New Horizon in Drug Development 126
Sustainable Ultrasound-Assisted Solid-Phase peptide synthesis (SUS-SPPS): Less Waste, more efficiency 125
Development of an efficient solid-phase synthetic methodology to construct a combinatorial library of a potent HDAC inhibitor. 124
Paper-based electrochemical device for early detection of integrin αvβ6 expressing tumors 120
New 2-Heterocyclyl-imidazo[2,1-i]purin-5-one Derivatives as Potent and Selective Human A(3) Adenosine Receptor Antagonists 118
Pyrrolyl Pyrazoles as Non-Diketo Acid Inhibitors of the HIV-1 Ribonuclease H Function of Reverse Transcriptase 118
Ligand-Based NMR Study of C-X-C Chemokine Receptor Type 4 (CXCR4)-Ligand Interactions on Living Cancer Cells 117
Identification of PR-SET7 and EZH2 selective inhibitors inducing cell death in human leukemia U937 cells 115
SIRT6 interacts with TRF2 and promotes its degradation in response to DNA damage 115
Switching Roles─Exploring Concentration-Dependent Agonistic versus Antagonistic Behavior of Integrin Ligands 112
Progresses in the pursuit of aldose reductase inhibitors: The structure-based lead optimization step 112
FK228 analogues induce fetal hemoglobin in human erythroid progenitors 110
Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors 107
The CXCR4 antagonist R54 targets epithelial-mesenchymal transition (EMT) in human ovarian cancer cells 103
HOPPI-NMR: Hot-Peptide-Based Screening Assay for Inhibitors of Protein-Protein Interactions by NMR 102
Novel alpha-MSH Peptide Analogues with Broad Spectrum Antimicrobial Activity 101
First-in-Class Cyclic Temporin L Analogue: Design, Synthesis, and Antimicrobial Assessment 97
Neuropeptide S receptor ligands: a patent review (2005-2016) 96
Urotensin-II Ligands: An Overview from Peptide to Nonpeptide Structures. 95
Reaction between (Z)-Arylchlorooximes and α-Isocyanoacetamides: A procedure for the synthesis of Aryl-α-ketoamide amides 95
Cigarette smoke destabilizes G-quadruplex structures and antagonizes G4-ligand effects in macrophages 56
Targeting Staphylococcus aureus with potent de novo-designed proline-core short antimicrobial lipopeptides 40
PyRMD Studio: A Unified Suite for Next-Generation, AI-Powered Virtual Screening 30
Probing Guanidino Pendant or Bridged Groups in Cyclic Antimicrobial Peptides Derived from Temporin L: A Strategy to Improve Efficacy against Gram-Negative Bacteria 26
Coupling PD-L1 Inhibition and Lysosomal Degradation: Innovative Anti-PD-L1 Peptides for NSCLC Immunotherapy 23
Development of Novel Proline- and Pipecolic Acid-Based Allosteric Inhibitors of Dengue and Zika Virus NS2B/NS3 Protease 23
Totale 10.212
Categoria #
all - tutte 33.312
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.312


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022363 0 0 0 7 108 12 9 20 17 59 31 100
2022/2023955 119 19 30 80 115 83 3 58 406 10 17 15
2023/2024392 50 11 28 25 92 39 6 20 2 3 34 82
2024/20251.399 15 16 18 47 209 154 155 113 269 171 107 125
2025/20265.461 179 304 279 292 473 2.960 190 268 206 146 107 57
2026/2027682 42 186 315 139 0 0 0 0 0 0 0 0
Totale 10.212